Fibrinogen-to-red blood cell ratio is associated with disease burden and short-term outcomes in hospitalized patients with gout: comparison with conventional inflammatory indices - Scorecard - MDSpire
Advertisement
Fibrinogen-to-red blood cell ratio is associated with disease burden and short-term outcomes in hospitalized patients with gout: comparison with conventional inflammatory indices
Clinical Scorecard: Association of Fibrinogen-to-Red Blood Cell Ratio with Disease Severity and Short-Term Outcomes in Hospitalized Gout Patients: A Comparison with Traditional Inflammatory Markers
At a Glance
Category
Detail
Condition
Gout
Key Mechanisms
Fibrinogen-to-red blood cell ratio (FRR) as a biomarker for inflammatory status and disease burden.
Target Population
Hospitalized patients with gout.
Care Setting
Department of Rheumatology, Shenzhen Traditional Chinese Medicine Hospital.
Key Highlights
High FRR associated with increased annual flares and tophi prevalence.
Stronger correlation of FRR with CRP and ESR compared to NLR and PLR.
High FRR linked to higher hospitalization costs and 30-day readmission rates.
Guideline-Based Recommendations
Diagnosis
Use 2015 ACR/EULAR gout classification criteria for diagnosis.
Management
Consider FRR as an adjunctive biomarker for assessing disease burden and inflammatory activity.
Monitoring & Follow-up
Monitor FRR alongside traditional inflammatory markers like CRP and ESR.
Risks
High FRR may indicate increased risk of complications such as proteinuria and longer hospital stays.
Patient & Prescribing Data
330 hospitalized patients with gout.
Data on medication use at admission includes corticosteroids, colchicine, NSAIDs, and urate-lowering therapy.
Clinical Best Practices
Integrate FRR into clinical assessments for hospitalized gout patients.
Utilize comprehensive inflammatory markers for better disease characterization.
The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.
